[L 1210 leukemia, an experimental model for the potentiation of drugs used for acute leukemias].
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D007700:Kinetics; D007938:Leukemia / Q000188:drug therapy; D007939:Leukemia L1210 / Q000188:drug therapy* / Q000401:mortality; D008727:Methotrexate / Q000008:administration & dosage; D051379:Mice; D008937:Mitomycins / Q000008:administration & dosage; D008954:Models, Biological; D009607:Nitrosourea Compounds / Q000008:administration & dosage; D013936:Thymidine; D014316:Tritium; D014750:Vincristine / Q000008:administration & dosage
D000970:Antineoplastic Agents; D008937:Mitomycins; D009607:Nitrosourea Compounds; D014316:Tritium; D014750:Vincristine; D003520:Cyclophosphamide; D005472:Fluorouracil; D013936:Thymidine; D008727:Methotrexate
La leucémie L1210, modèle expérimental pour la potentialisation des drogues applicables aux leucémies aigües